Modeling the spread of COVID-19 in Germany: Early assessment and possible scenarios MV Barbarossa, J Fuhrmann, JH Meinke, S Krieg, HV Varma, N Castelletti, ... Plos one 15 (9), e0238559, 2020 | 90 | 2020 |
In search of the SARS-CoV-2 protection correlate: head-to-head comparison of two quantitative S1 assays in pre-characterized oligo-/asymptomatic patients R Rubio-Acero, N Castelletti, V Fingerle, L Olbrich, A Bakuli, R Wölfel, ... Infectious diseases and therapy 10 (3), 1505-1518, 2021 | 70 | 2021 |
Prevalence and risk factors of infection in the representative COVID-19 cohort Munich M Pritsch, K Radon, A Bakuli, R Le Gleut, L Olbrich, ... International Journal of Environmental Research and Public Health 18 (7), 3572, 2021 | 63 | 2021 |
Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19) K Radon, E Saathoff, M Pritsch, JM Guggenbühl Noller, I Kroidl, L Olbrich, ... BMC public health 20, 1-9, 2020 | 50 | 2020 |
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany) K Radon, A Bakuli, P Pütz, R Le Gleut, JM Guggenbuehl Noller, L Olbrich, ... BMC infectious diseases 21, 1-15, 2021 | 32 | 2021 |
Broad T cell targeting of structural proteins after SARS-CoV-2 infection: high throughput assessment of T cell reactivity using an automated interferon gamma release assay I Brand, L Gilberg, J Bruger, M Garí, A Wieser, TM Eser, J Frese, ... Frontiers in Immunology 12, 688436, 2021 | 28 | 2021 |
Comparison of signalment, clinical, laboratory and radiographic parameters in cats with feline asthma and chronic bronchitis M Grotheer, J Hirschberger, K Hartmann, N Castelletti, B Schulz Journal of feline medicine and surgery 22 (7), 649-655, 2020 | 27 | 2020 |
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2 L Olbrich, N Castelletti, Y Schälte, M Garí, P Pütz, A Bakuli, M Pritsch, ... Journal of General Virology 102 (10), 001653, 2021 | 23 | 2021 |
A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay J Beyerl, R Rubio-Acero, N Castelletti, I Paunovic, I Kroidl, ZN Khan, ... EBioMedicine 70, 2021 | 22 | 2021 |
Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich-One year of experience R Rubio-Acero, J Beyerl, M Muenchhoff, MS Roth, N Castelletti, ... Science of The Total Environment 797, 149031, 2021 | 21 | 2021 |
Risk of lung adenocarcinoma from smoking and radiation arises in distinct molecular pathways N Castelletti, JC Kaiser, C Simonetto, K Furukawa, H Küchenhoff, ... Carcinogenesis 40 (10), 1240-1250, 2019 | 21 | 2019 |
Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers–ORCHESTRA project G Collatuzzo, G Visci, FS Violante, S Porru, G Spiteri, MGL Monaco, ... Frontiers in immunology 13, 986085, 2022 | 20 | 2022 |
The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2–Results from a prospective cohort of outpatient COVID-19 cases K Puchinger, N Castelletti, R Rubio-Acero, C Geldmacher, TM Eser, ... Virology 569, 37-43, 2022 | 11 | 2022 |
Prediction of surface area size in orbital floor and medial orbital wall fractures based on topographical subregions CP Cornelius, T Stiebler, P Mayer, W Smolka, C Kunz, B Hammer, ... Journal of Cranio-Maxillofacial Surgery 49 (7), 598-612, 2021 | 9 | 2021 |
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections MIM Ahmed, P Diepers, C Janke, M Plank, TM Eser, R Rubio-Acero, ... Frontiers in immunology 13, 1026473, 2022 | 8 | 2022 |
Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion TM Eser, O Baranov, M Huth, MIM Ahmed, F Deák, K Held, L Lin, ... Nature Communications 14 (1), 2952, 2023 | 7 | 2023 |
Estimating long-term health risks after breast cancer radiotherapy: merging evidence from low and high doses C Simonetto, D Wollschläger, P Kundrát, A Ulanowski, J Becker, ... Radiation and Environmental Biophysics 60 (3), 459-474, 2021 | 7 | 2021 |
Incidence and determinants of symptomatic and asymptomatic SARS-CoV-2 breakthrough infections after booster dose in a large European multicentric cohort of health workers … S Porru, MGL Monaco, G Spiteri, A Carta, G Caliskan, C Violán, ... Journal of Epidemiology and Global Health 13 (3), 577-588, 2023 | 6 | 2023 |
Determinants of Anti-S Immune Response at 9 Months after COVID-19 Vaccination in a Multicentric European Cohort of Healthcare Workers—ORCHESTRA Project G Collatuzzo, V Lodi, D Feola, G De Palma, E Sansone, E Sala, C Janke, ... Viruses 14 (12), 2657, 2022 | 5 | 2022 |
Integrative modelling of reported case numbers and seroprevalence reveals time-dependent test efficiency and infectious contacts L Contento, N Castelletti, E Raimúndez, R Le Gleut, Y Schälte, P Stapor, ... Epidemics 43, 100681, 2023 | 4 | 2023 |